Threshold Pharmaceuticals
Jun 1, 2016
PDF

Threshold Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference

Company Presentation Scheduled for June 7, 2016 at 3:30 p.m. ET

SOUTH SAN FRANCISCO, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the Jefferies 2016 Healthcare Conference at the Grand Hyatt in New York City on June 7, 2016 at 3:30 p.m. Eastern Time.

To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the Company's web site at www.thresholdpharm.com. Please connect to the web site at least 15 minutes prior to the presentation to allow for any software download that may be necessary. An archived replay will be available for 30 days beginning 24 hours after the live presentation.

About Threshold Pharmaceuticals
Threshold is a clinical-stage biopharmaceutical company focused on the discovery and development of drugs and diagnostic agents targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit the Company's website.

Contact

Denise Powell

denise@redhousecomms.com

510.703.9491

Primary Logo

Source: Threshold Pharmaceuticals, Inc.

News Provided by Acquire Media